Laboratory of Organic Chemistry, Department of Chemistry, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece.
Bioorg Med Chem Lett. 2009 Nov 15;19(22):6433-6. doi: 10.1016/j.bmcl.2009.09.040. Epub 2009 Sep 17.
9-(3-Mesityl-4,5-dihydroisoxazol-5-yl) homo-N-nucleosides were prepared from the 1,3-dipolar cycloaddition reactions of mesityl nitrile oxide with 9-allyl derivatives of 6-chloropurine, 6-piperidinylpurine, 6-morpholinylpurine, 6-pyrrolidinylpurine, and 6-N,N-dibenzoyladenine. The new compounds were tested in vitro for their ability: (i) to interact with 1,1-diphenyl-2-picryl-hydrazyl (DPPH) stable free radical, (ii) to inhibit lipid peroxidation, (iii) to scavenge the superoxide anion, (iv) to inhibit the activity of soybean lipoxygenase, and (v) to inhibit in vitro thrombin. Most of them found to be potent thrombin inhibitors and to inhibit in vitro lipid peroxidation. The majority of the compounds showed significant lipoxygenase inhibitory activity.
9-(3-均三甲苯基-4,5-二氢异恶唑-5-基)同型-N-核苷由均三甲苯腈氧化物与 9-烯丙基 6-氯嘌呤、6-哌啶基嘌呤、6-吗啉基嘌呤、6-吡咯烷基嘌呤和 6-N,N-二苯甲酰基腺嘌呤的 1,3-偶极环加成反应制备。这些新化合物在体外进行了以下能力测试:(i)与 1,1-二苯基-2-苦基肼基(DPPH)稳定自由基相互作用,(ii)抑制脂质过氧化,(iii)清除超氧阴离子,(iv)抑制大豆脂氧合酶的活性,以及(v)抑制体外凝血酶。它们中的大多数被发现是有效的凝血酶抑制剂,并能抑制体外脂质过氧化。大多数化合物表现出显著的脂氧合酶抑制活性。